James Love's blog

38 groups (including KEI) ask Congress to make CRS reports public

Congressional Research Service reports are prepared in response to requests from members of congress. For decades, right to know groups have been asking that they be available online. The CRS describes itself as follows:

Greens/EFA MEPs Engström, Sargentini, Beliér, Albrecht ask question on ACTA and Vienna Convention

Four Green/EFA MEPs (from four parties and four countries) have asked a follow-up question on ACTA and the Vienna Connection, trying to get at the "is the US bound?" issue.

4meps.jpg
Greens/EFA MEPs Christian Engström, Judith Sargentini, Sandrine Beliér and Jan Albrecht have asked the European Commission this follow-up question on ACTA and Vienna Convention:

Judit Rius takes position as U.S. Manager of MSF's Campaign for Access to Essential Medicines

At the end of the month, Judit Rius will be leaving KEI and joining MSF in New York as U.S. Manager of MSF's Campaign for Access to Essential Medicines. Judit has been with KEI since 2006, and from the beginning, contributed greatly to nearly every aspect of KEI's work. We will miss her a lot. At MSF, Judit will work closely with another talented former KEI lawyer, Michelle Childs. We wish Judit well in her new position, and congratulate MSF on the appointment.

WHO Executive Board accepts appointment of Herrling to Consultative Expert Working Group on R&D

After several days of negotiations, the 128th WHO Executive Board has accepted the nomination of Paul Herrling to the new WHO Consultative Expert Working Group on R&D Financing, despite the fact that Herrling is an executive of Novartis, and is the author of the IFPMA/Novartis/FRIND proposal and the co-author of the PDP Plus proposal, which will be considered by the CEWG.

Ska Keller tables MEP question on ethical aspects of pharmaceutical test data protection

On Tuesday the 18th of January 2010,German Green MEP Franziska Keller tabled this Parliamentary question: ska-keller.jpg

The WHO EB debate over membership of the new R&D Financing consultative expert working group (CEWG)

At the end of the day on Monday, the 128 WHO Executive Board meeting took the agenda item for creation of a new R&D Financing consultative expert working group (CEWG). (Yesterday's blog on this topic is here)

World Health Organization Executive Board to create new consultative expert working group on R&D Financing

Today the WHO is expected to take up the Report by the Secretariat on "the Establishment of a consultative expert working group on research and development: financing and coordination." (link here).

Google hits by domain using search term "Gates Foundation"

The following reports the number of Google hits using the search term "gates foundation," with a site:domainname option, on January 7, 2011. The result is a count of the number of web pages (visible to Google) mentioning the Gates Foundation on a particular domain.

For example, the google search site:who.int "gates foundation" identified 5,940 pages on the who.int web site that have the exact phrase, "gates foundation."


Life Technologies funds seven $1 million medical innovation prizes

On December 14, 2010, Life Technologies Corporation, which among other things owns Ion Torrent, which sells the Ion Personal Genome Machine sequencer, announced seven new medical innovation prizes. The first three prizes are related to improvements in the Ion semiconcudtor sequencing products. Each of the three sequencer prizes is funded at $1 million, and will be awarded to contestants that can achieve the following goals:

  1. produce twice as much sequence data,

NSF, Gates Foundation policies on sharing data and intellectual property in agricultural basic research grant program (BREAD)

The US based National Science Foundation (NSF) and the Bill and Melinda Gates Foundation are collaborating on a program called Basic Research to Enable Agricultural Development (BREAD). A May 12, 2010 NSF announcement about the program is available here.

Cancer: Annual deaths compared to new cases in 2004, for 16 types of cancer and 4 World Bank income groups

The following table compares the annual deaths from cancer, to the annual incidence of the disease, broken down by cancer type and income group. The data in the table is annual deaths divided by annual incidence, show as a ratio.

For several types of cancer, there is not much difference in the reported ratios, between different income groups. For other types of cancer, the differences are large, and in favor of patients living in higher income countries. Cancer types with the largest disparities by income include the following:

  • Mouth and oropharynx cancers

Ratio of year 2000 breast cancer deaths to new breast cancer patients in Europe, by country and country income

The following graph presents the year 2000 raw mortality rate of breast cancer patients in 36 European Countries. The graph compares the ratio of breast cancer deaths to the annual incidence of breast cancer, to the per capita incomes in those countries, all based upon year 2000 data.

USTR's Request for Comments on ACTA

USTR has issued a request for comments on ACTA. The deadline for submissions is February 15, 2011. The notice gives very little guidance regarding the issues the USTR would like addressed in the comments.


[Billing Code 3190-W1-P]

Office of the United States Trade Representative

Anti-Counterfeiting Trade Agreement: Request for Comments from the Public

Agency: Office of the United States Trade Representative

Action: Request for written submissions from the public

Notes from meeting with USTR on the TPP IPR chapter

Today USTR provided some additional insight into negotiations of a regional, Asia-Pacific trade agreement, known as the Trans-Pacific Partnership (TPP) Agreement. The USTR web page on the TPP negotiations is http://www.ustr.gov/tpp. At present, the TPP negotiators include Australia, Brunei Darussalam, Chile, New Zealand, Peru, Singapore and Vietnam. Japan and Canada have expressed interest in joining the negotiations, and USTR clearly would like to design an agreement that will be open to other countries. Our discussions focused on the intellectual property chapter in the agreement.

Syndicate content